Veritable
FRLN

Veritable’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Veritable’s Portfolio FRLN Stock Details FRLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,725
Closed -$63K – 975
2022
Q1 		$63K Hold
3,725
– – ﹤0.01% 895
2021
Q4 		$111K Hold
3,725
– – ﹤0.01% 894
2021
Q3 		$191K Buy
+3,725
New +$265K ﹤0.01% 852

Other funds holding FRLN

Syncona Portfolio
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
CHI Advisors
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
TFG Asset Management
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Harbor Capital Advisors
Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Veritable's FRLN Position: Q2 2022 in Review

Veritable sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q2 2022, closing a stake of 3,725 shares — an estimated $63K sold.

Veritable first reported a position in FRLN in Q3 2021 and held it in 3 quarters. The position peaked at $191K in Q3 2021. 17 funds tracked by Wall St. Rank hold FRLN as of Q2 2022.

  • Veritable reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q2 2022 after selling out during the quarter.
  • Veritable sold 3,725 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q2 2022, an estimated $63K.
  • Veritable first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q3 2021 and held it in 3 quarters.
  • Veritable's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $191K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q2 2022.

Based on Veritable's 13F filing for Q2 2022, filed 15 Aug 2022.